Placental Transfer of Sugammadex in the Human Placental Perfusion Model

Summary

Preclinical research raised concern regarding the foetal effects of using sugammadex during pregnancy. However, to the best of our knowledge, the placental transfer of sugammadex has never been measured. As these data would be critical in assessing the foetal effects after maternal administration of sugammadex, it is warranted to measure the placental transfer of sugammadex. The aim of this project is to measure the placental transfer of sugammadex in the human placenta by using the ex vivo human placenta perfusion model.

Timeline

Start

2025-03-17

Primary completion

2026-09

Completion

2026-09

Drugs

Indications